Drug Profile
ADP 31415
Alternative Names: ADP-31415Latest Information Update: 28 Dec 2019
Price :
$50
*
At a glance
- Originator Almirall S.A.
- Class Pyrimidines; Pyrroles; Skin disorder therapies; Small molecules
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pemphigus vulgaris